Excelsior Biopharma Inc. (TPEX:6496)
26.20
-0.85 (-3.14%)
At close: Mar 9, 2026
Excelsior Biopharma Market Cap
Excelsior Biopharma has a market cap or net worth of 1.22 billion as of March 9, 2026. Its market cap has decreased by -16.54% in one year.
Market Cap
1.22B
Enterprise Value
1.55B
Revenue
898.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.20
Market Cap Chart
Since December 23, 2014, Excelsior Biopharma's market cap has decreased from 2.86B to 1.22B, a decrease of -57.24%. That is a compound annual growth rate of -7.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DV Biomed | 1.34B |
| Anxo Pharmaceutical | 1.13B |
| Original BioMedicals | 1.11B |
| Winston Medical Supply | 1.48B |
| Mediera | 1.06B |
| Prince Pharmaceutical | 1.05B |
| InnoPharmax | 1.65B |
| Tien Liang BioTech | 1.65B |